It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveAurazen Pharmaceutical Private Limited, a active private limited company, was established on 17 December 2020 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100MH2020PTC352076. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Sugandha Sunil Kubal (Director), Rutuja Yatin Shelar (Director), Shreeya Yatin Shelar (Director). Past directors included Sugandha Sunil Kubal, Shreeya Yatin Shelar, Himanshu Alkesh Potdar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Wadhwa, 1604, C-Wing, Atmosphere Realty Suburban Greater Mumbai, Mulund W, Mumbai, Maharashtra, 400080.
U24100MH2020PTC352076
352076
17 December 2020
₹1.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Aurazen Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sugandha Sunil Kubal | Director | 21 Aug 2023 | Current |
| Rutuja Yatin Shelar | Director | 17 Dec 2020 | Current |
| Shreeya Yatin Shelar | Director | 08 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 16 Sep 2022 | Past |
| Pramod Abcsdd | Director | 08 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurazen Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 506.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 200.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aurazen Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aurazen Pharmaceutical has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurazen Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurazen Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aurazen Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Aurazen Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Sugandha Sunil Kubal was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
Shreeya Yatin Shelar was appointed as a Director was appointed as a Director on 08 Aug 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.
The activity Rutuja Yatin Shelar was appointed as a Director was appointed as a Director on 17 Dec 2020 & has been associated with this company since 4 years 11 months . was completed.
Progress on Aurazen Pharmaceutical Private Limited was registered on 17 Dec 2020 with Roc Mumbai & aged 4 years 11 months as per MCA records. was documented.
The CIN of Aurazen Pharmaceutical Private Limited is U24100MH2020PTC352076.
Aurazen Pharmaceutical Private Limited is headquartered at Wadhwa, 1604, C-Wing, Atmosphere Realty Suburban Greater Mumbai, Mulund W, Mumbai, Maharashtra, 400080.
Aurazen Pharmaceutical Private Limited was incorporated on 17 December 2020.
The current directors of Aurazen Pharmaceutical Private Limited are
The primary industry of Aurazen Pharmaceutical Private Limited is Pharma.
Aurazen Pharmaceutical Private Limited is unlisted.
The authorized capital of Aurazen Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX